It looks like you are visiting from outside the EU. Switch to the US version to see local pricing in USD and local shipping.

Switch to US ($)
Contact +33 (0)3 90 20 54 70
  • Reinventing IgY biotherapeutics
    Antibody production

    Reinventing IgY biotherapeutics

    Ana Reis, PhD Ana Reis, PhD 14 min read

    An unorthodox project idea led Dr. Mara Freire, a researcher at CICECO – Aveiro Institute of Materials, from the Chemistry Department of the University of Aveiro (Portugal), to a solution…

  1. Protein production

    Applications of the XtenCHO™ Race transient expression system

    Read more
  2. Antibody production

    The 5 Pillars of Excellence in Stable Cell Line Development

    Read more
  3. Antibody production

    Fundamental and advanced methods to improve monoclonal antibody production in vitro

    Read more
  4. Antibody production

    Budget Busters: How to Manage Costs and Resources in Antibody Development

    Read more
  5. Antibody production

    Polyclonal antibody production processes and development for research and diagnostics

    Read more

Let’s talk about science – Scientists in the spotlight

Dr. Louisa James

“The COVID-19 pandemic is helping us bridge the divide between virologists and immunologists”

Read more
Queen Mary University of London (QMUL, UK) Queen Mary University of London (QMUL, UK)
“The COVID-19 pandemic is helping us bridge the divide between virologists and immunologists”
Dr. Mara Freire

Reinventing IgY biotherapeutics

Read more
CICECO, University of Aveiro CICECO, University of Aveiro
Reinventing IgY biotherapeutics
Dr. Melanie Conrad

How the environment shapes immune system development during pregnancy

Read more
Charité Medical University in Berlin Charité Medical University in Berlin
How the environment shapes immune system development during pregnancy
Dr. Mohamed Alfaleh

“Cell-based phage display is helping us isolate more biologically relevant antibodies”

Read more
King Abdulaziz University King Abdulaziz University
“Cell-based phage display is helping us isolate more biologically relevant antibodies”
Prof. Tomáš Kalina

“Researchers are not leveraging the speed and resolution of flow cytometry for clinical evaluation”

Read more
Charles University in Prague Charles University in Prague
“Researchers are not leveraging the speed and resolution of flow cytometry for clinical evaluation”
Prof. Richard Pleass

“Antibodies will make a significant contribution to design effective control strategies for COVID-19”

Read more
LSTM LSTM
“Antibodies will make a significant contribution to design effective control strategies for COVID-19”
Professor Istvan Toth

“Simplicity is the key to successful large-scale applications”

Read more
Queensland University, Australia Queensland University, Australia
“Simplicity is the key to successful large-scale applications”
See More

Read by topic

Cart (0 Items)

Your cart is currently empty.

View Products